CD274 and neoplasm: In Patient 7, PD‐L1 was positive during patient care (TPS score = 90%, 22‐C3 PD‐L1 antibody clone) and had PD‐L1 TPS scores in the postmortem tissue of ≥40% for two RTD tumor sites with the E1L3N and 28‐8 clones.